Resistance of HBV and HCV to antiviral therapies

ISSN： 1746-0794

Source： Future Virology, Vol.3, Iss.3, 2008-05, pp. : 221-224

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Resistance Mutations Against HCV Protease Inhibitors and Antiviral Drug Design

Current Pharmaceutical Design, Vol. 20, Iss. 5, 2014-02 ,pp. : 694-703

Bentham Science Publishers

Access to resources Recommend Favorite

Treatment of HBV/HCV coinfection

By Potthoff Andrej Manns Michael P Wedemeyer Heiner

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 6, 2010-04 ,pp. : 919-928

Informa Healthcare

Access to resources Recommend Favorite

Antiviral Drugs in the Prophylaxis of HBV Infection

Current Medicinal Chemistry, Vol. 19, Iss. 35, 2012-12 ,pp. : 5940-5946

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular diagnosis of occult HCV and HBV infections

By Michalak Tomasz I Pham Tram NQ Mulrooney-Cousins Patricia M

Future Virology, Vol. 2, Iss. 5, 2007-09 ,pp. : 451-465

Future Medicine

Access to resources Recommend Favorite

Antifibrogenic Therapies in Chronic HCV Infection

Current Drug Targets - Infectious Disorders, Vol. 1, Iss. 2, 2001-08 ,pp. : 227-240

Bentham Science Publishers

Access to resources Recommend Favorite